Lower FY22 PDUFA Fees Realized In US FDA Recalculation For Hiring, Attrition Concerns
Executive Summary
Agency reissued user fee notice, saying fewer dollars were needed for adding staff. After concerns about process misunderstandings, agency withdrew earlier version of fee notice.